Introducing a novel excipient to formulate poorly soluble APIs and injectable depots
Selecting the right excipient is so important in the drug development process. If you’re dealing with poorly water-soluble APIs or are interested in a new excipient for injectable, extended-release dosages, Eastman can help.
To view our recent webinar “Eastman BioSustane™ SAIB NF: a multifunctional, novel excipient already in approved formulations,"
click here and complete the form to get a link to the recording delivered to your inbox.